Brazilian study reveals how medical cannabis works in daily life
NCT ID NCT07362407
First seen Jan 25, 2026 · Last updated Jun 11, 2026 · Updated 20 times
Summary
This study follows 384 patients in Brazil who are using cannabis-based products prescribed by their doctors for chronic pain, anxiety, or depression. Researchers will not provide the medication but will track patients' progress over 6 months through online questionnaires. The goal is to understand how well these treatments work and how safe they are in real-world conditions, helping doctors and health authorities make better decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Universidade Federal de Santa Catarina (UFSC), Centro de Ciências Biológicas (CCB), Campus Universitário, Trindade, Florianópolis - SC.
Florianópolis, Santa Catarina, 88049-900, Brazil
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.